DIPENTUM

This brand name is authorized in Australia, Canada, Finland, France, Ireland, Netherlands, New Zealand, United States, South Africa

Active ingredients

The drug DIPENTUM contains one active pharmaceutical ingredient (API):

1 Olsalazine UNII Y7JEW0XG7I - OLSALAZINE SODIUM

Olsalazine is bioconverted to 5-aminosalicylic acid (5-ASA), which has anti-inflammatory activity in ulcerative colitis. The conversion of olsalazine to mesalamine (5-ASA) in the colon is similar to that of sulfasalazine, which is converted into sulfapyridine and mesalamine. The mechanism of action of mesalamine (and sulfasalazine) is unknown, but appears to be topical rather than systemic. Read about Olsalazine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIPENTUM Capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07EC03	Olsalazine	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EC Aminosalicylic acid and similar agents
Discover more medicines within A07EC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1728Y, 8086N
Country: CA	Health Products and Food Branch	Identifier(s): 02063808
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 531956
Country: FR	Base de données publique des médicaments	Identifier(s): 63634128, 64457645
Country: IE	Health Products Regulatory Authority	Identifier(s): 21782, 21828
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 25577, 32697
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5127, 5129
Country: US	FDA, National Drug Code	Identifier(s): 0037-6860
Country: ZA	Health Products Regulatory Authority	Identifier(s): V/11.9.2/301